| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/28/2002 | US6395283 Equine herpesvirus type 1 glyocoprotein D (EHV-1gD) |
| 05/28/2002 | US6395282 Carrier molecule conjugated to specific autoinducers; vaccines for the treatment and prevention of infection |
| 05/28/2002 | US6395280 Deodorant agents for oral use for discharges and method for relieving odor of discharges |
| 05/28/2002 | US6395278 Prostate specific fusion protein compositions |
| 05/28/2002 | US6395276 Killing malignant b cells by contacting with protein having ribonuclease activity linked to antibody against b cell surface marker; anticancer agents |
| 05/28/2002 | US6395275 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 05/28/2002 | US6395272 Therapeutic compounds comprised of anti-Fc receptor antibodies |
| 05/28/2002 | US6395267 Inhibiting signal transduction in tumor necrosis factor receptors by identifying molecule that binds to specific amino acid sequence of human receptor, then bringing molecule in contact with receptor |
| 05/28/2002 | CA2121256C Secreted mac-2-binding glycoprotein |
| 05/28/2002 | CA2071651C A parenterally administrable drug having thrombolytic activity and containing protein c |
| 05/28/2002 | CA2032653C Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 05/23/2002 | WO2002040720A2 Compositions and methods relating to ovary specific genes and proteins |
| 05/23/2002 | WO2002040681A1 The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 05/23/2002 | WO2002040676A2 Mutant allergens |
| 05/23/2002 | WO2002040639A2 Methods for enhancing engraftment of purified hematopoietic stem cells in allogeneic recipients |
| 05/23/2002 | WO2002040541A2 Transporters and ion channels |
| 05/23/2002 | WO2002040540A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | WO2002040535A2 Compositions and methods relating to ovary specific genes and proteins |
| 05/23/2002 | WO2002040518A1 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant |
| 05/23/2002 | WO2002040517A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002040516A2 Helicobacter cysteine rich protein a (hcpa) and uses thereof |
| 05/23/2002 | WO2002040515A2 Exoenzyme toxin of aeromonas salmonicida, and uses thereof |
| 05/23/2002 | WO2002040514A2 Type iii secretion pathway in aeromonas salmonicida, and uses therefor |
| 05/23/2002 | WO2002040513A2 Nucleic acid vaccine comprising a fusion protein including an adjuvant sequence from a plant viral coat protein |
| 05/23/2002 | WO2002040511A2 Dna sequence and microcine from escherichia coli strain dsm 6601 |
| 05/23/2002 | WO2002040509A1 Antibody against norwalk virus and method of detecting virus by using the antibody |
| 05/23/2002 | WO2002040499A1 A method for generating genetically altered antigens |
| 05/23/2002 | WO2002040059A2 Methods and compositions for inducing cell-mediated immune responses |
| 05/23/2002 | WO2002040051A1 Colostrum-based composition |
| 05/23/2002 | WO2002040050A1 Non-lethal methods for conditioning a recipient for bone marrow transplantation |
| 05/23/2002 | WO2002040049A2 Blockade of t cell migration into epithelial gvhd target tissues |
| 05/23/2002 | WO2002040046A1 Salmonella vaccine |
| 05/23/2002 | WO2002040044A2 Chemoattractant recruitment of dendritic cells for enhancement of immunization |
| 05/23/2002 | WO2002040038A2 M. tuberculosis chaperonin 10 and uses thereof |
| 05/23/2002 | WO2002040037A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002039985A1 Parenterally administrable microparticles |
| 05/23/2002 | WO2002039951A2 Yeast-dentritic cell vaccines and uses thereof |
| 05/23/2002 | WO2002039885A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/23/2002 | WO2002032451A8 Vaccine composition comprising an antigen and a peptide having adjuvant properties |
| 05/23/2002 | WO2002015931A9 Immunologic method for the prevention of dental caries |
| 05/23/2002 | WO2002004603A3 Method for the modification of biological cells |
| 05/23/2002 | WO2002003911B1 Prevention and treatment of alzheimer's disease |
| 05/23/2002 | WO2001093804A3 Hepatitis c virus conjugates |
| 05/23/2002 | WO2001092484A3 Adjuvant preparation for the induction of specific immunity |
| 05/23/2002 | WO2001092313A3 Methods for isolating and using fungal hemolysins |
| 05/23/2002 | WO2001090182A3 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 05/23/2002 | WO2001087346A3 Dendritic cells loaded with toxic substances |
| 05/23/2002 | WO2001085911A3 Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes |
| 05/23/2002 | WO2001085208A3 Molecular antigen arrays and vaccines |
| 05/23/2002 | WO2001083720A3 23686, a novel human aminotransferase and uses therefor |
| 05/23/2002 | WO2001082948A3 Uses of tgap7 for the modulation of leucocyte activation |
| 05/23/2002 | WO2001081577A3 Dna encoding the prost 03 polypeptide |
| 05/23/2002 | WO2001080887A3 Methods and chemokin compositions for inducing an immune response |
| 05/23/2002 | WO2001079444A3 Albumin fusion proteins |
| 05/23/2002 | WO2001079277A3 Immunogenic pili presenting foreign peptides, their production and use |
| 05/23/2002 | WO2001074386A3 Cold-adapted equine influenza viruses |
| 05/23/2002 | WO2001072294A3 Method of treating hepatitis delta viral infection |
| 05/23/2002 | WO2001063295A3 Dpi-6, a therapeutic biomarker in neurological disorders |
| 05/23/2002 | WO2001049720A3 Chemically modified hiv envelope glycoprotein |
| 05/23/2002 | WO2001040469A3 Tick antigens and compositions and methods comprising them |
| 05/23/2002 | WO2001040271A9 Cancer associated antigens and uses therefor |
| 05/23/2002 | WO2001037872A9 'bonzo' chemokine receptor antibodies and ligands |
| 05/23/2002 | US20020062488 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 05/23/2002 | US20020062009 Monoclonal antibodies with reduced immunogenicity |
| 05/23/2002 | US20020062008 Novel human beta2 integrin alpha subunit |
| 05/23/2002 | US20020061926 Pharmaceutical composition and method of using the same |
| 05/23/2002 | US20020061859 Antisense oligonucleotides and antibodies which inhibit its expression or biological activity |
| 05/23/2002 | US20020061848 An specific polypeptides comprising a Chlamydia antigen and the use of such polypeptides for the serodiagnosis and treatement of Chlamydia infection |
| 05/23/2002 | US20020061846 Administering to a mammal Group B- beta hemolytic streptococci(GBS) toxin receptors or immunogenic fragments to induce an immune response to the GBS receptors for prventing pathoangiogenic conditions |
| 05/23/2002 | US20020061834 Human G-protein Chemokine receptor (CCR5) HDGNR10 |
| 05/23/2002 | US20020061589 Method of immunotherapy; obtain electrodes, obtain waveform generator, generate electrically conductive pathways between electrodes and generator, incubate with transfer particles, transfer particles into cells with electrical pulse |
| 05/23/2002 | US20020061573 Nucleotide seqences which code enzymatic polypeptide for use in diagnosis and treatment of cell propagation defects, pain, eating, urogenital and brain disorders, cachexia and diabetes |
| 05/23/2002 | US20020061559 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents |
| 05/23/2002 | US20020061553 Partners of the PTB1 domain of FE65, preparation and uses |
| 05/23/2002 | US20020061545 Streptococcus pneumoniae antigens and vaccines |
| 05/23/2002 | US20020061543 Diagnosing cancer in humans; obtain tissue, monitor transcription factor expression, compare to control, amplified expression indicates cancer |
| 05/23/2002 | US20020061517 Adenovirus carrying gag gene HIV vaccine |
| 05/23/2002 | US20020061336 Also comprising a hydrogel, for use in the treatment of a subject by particle injection |
| 05/23/2002 | US20020061316 Immunotherapeutic stress protein-peptide complexes against cancer |
| 05/23/2002 | US20020061315 Delivering allergen directly into lymph node of individual |
| 05/23/2002 | US20020061314 Administering to animal live vaccine containing organisms to develop immunological response, maintaining animal free from drugs effective against infectious organism for period of one life or infectious cycle of organism, administering drug |
| 05/23/2002 | US20020061313 Non-infectious, protease defective HIV particles and nucleic acid molecules encoding therefor |
| 05/23/2002 | US20020061312 Fusion protein comprising an isolated pathogen associated molecular pattern or an immunostimulatory portion or immunostimulatory derivative thereof and an antigen or an immunogenic portion or immunogenic derivative thereof |
| 05/23/2002 | US20020061311 For prevention or treatment of autoimmune diseases/influenza and clinical allergic hypersensitivities, and for prevention of allograft rejection |
| 05/23/2002 | US20020061310 Compositions and methods for dendritic cell-based immunotherapy |
| 05/23/2002 | US20020061309 Production of peptides in plants as N-terminal viral coat protein fusions |
| 05/23/2002 | US20020061307 Polyalkylene oxide-modified single chain polypeptides |
| 05/23/2002 | US20020061306 DNA sequences encoding proteins having ability to bind alpha 2-macroglobulin; expression vectors; immunology |
| 05/23/2002 | US20020061304 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 05/23/2002 | US20020061292 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 05/23/2002 | DE10126367A1 Pharmaceutical composition comprises Borrelia antigens and encoding nucleic acid, useful for diagnosis, treatment and prevention of Lyme borreliosis |
| 05/23/2002 | DE10057443A1 Use of specific antibodies, or individual chains, for treating tumors and vascular occlusions, by inhibition of the gpIIb/IIIa receptor |
| 05/23/2002 | CA2856033A1 Use of a monoclonal antibody specific for a leukocyte to inhibit the reticuloendothelial system for the treatment of thrombocytopenia |
| 05/23/2002 | CA2771909A1 Proteins producing an altered immunogenic response and methods of making and using the same |
| 05/23/2002 | CA2749307A1 Promoter sequence of a gene encoding an exoenzyme toxin of aeromonas salmonicida, and uses therefor |
| 05/23/2002 | CA2707684A1 Novel exoenzyme toxin of aeromonas salmonicida, and uses therefor |
| 05/23/2002 | CA2467360A1 Exoenzyme toxin of aeromonas salmonicida, and uses therefor |
| 05/23/2002 | CA2467309A1 Type iii secretion pathway in aeromonas salmonicida, and uses therefor |
| 05/23/2002 | CA2429897A1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/23/2002 | CA2429894A1 M. tuberculosis chaperonin 60.1 and uses thereof |